Grindr announces PurposeMed deal as Grindr stock enters health care

Published on 10/01/2026 at 14:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

PurposeMed is valued at USD 250.00 million, including USD 190.00 million in cash. Grindr stock forms USD 60.00 million of the consideration.

GRND, US3985791090, Illustration mit AI erstellt.

On September 30, 2026, Grindr announced a PurposeMed acquisition valued at USD 250.00 million as Grindr stock expands into health care. According to Grindr, the agreement covers PurposeMed, the parent company of Freddie, a telehealth provider focused on PrEP and HIV prevention.

Deal terms set a clear price

The consideration comprises USD 190.00 million in cash and USD 60.00 million in Grindr common stock, with up to USD 70.00 million in additional cash tied to PurposeMed performance in fiscal year 2027. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions.

The SEC filing dated September 30, 2026, says the stock consideration represents 3,851,684 shares valued at USD 15.58 each, based on the 15 trading days through September 29, 2026. The filing also allows termination if closing has not occurred by December 30, 2026.

Revenue growth supports expansion

Grindr entered the deal after reporting USD 138.00 million of revenue in the second quarter of 2026, a 33.00 percent increase from the second quarter of 2025. According to Benzinga on September 17, 2026, adjusted EBITDA reached USD 58.00 million and represented a 42.00 percent margin.

Management raised full-year 2026 revenue guidance to USD 540.00 million from USD 535.00 million and adjusted EBITDA guidance to USD 232.00 million from USD 227.00 million. The comparison points to USD 5.00 million of additional revenue and USD 5.00 million of additional adjusted EBITDA in the updated outlook.

Health care adds execution risk

Freddie has served more than 55,000 patients across the United States and Canada and operates across all 50 US states, according to the September 30, 2026 company release. The acquisition gives Grindr access to telehealth, testing, prescriptions and medication delivery, but it also moves the company into a regulated health care market with privacy, compliance and integration requirements.

Grindr's primary listing is on the New York Stock Exchange. On September 30, 2026, the stock last stood at USD 15.43 at 4:00 p.m. ET, while its 52-week range was USD 9.73 to USD 18.50 and market capitalization was USD 2.7 billion.